NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)

Source: sbir.gov Agency: HHS Branch: NIH Program: SBIR Phase II Topic: PA-27-101 Research Area: Status: open

Eligibility

Small businesses (< 500 employees), US-owned

small_business

Similar opportunities

grant

SBA

SBIR/STTR Commercialization Readiness Pilot (SB1)

Source: sbir.gov Agency: SBA Branch: SBA Program: SBIR Phase CRP Topic: SB1-2026 Research Area: Commercialization / Technology Transfer / Innovation Status: new Requirements: Commercialization Readiness Pilot program to help SBIR/STTR awardees transition technologies to market.

$2,153,927Apr 6, 2027

grant

NIH

NIH SBIR Phase IIB Strategic Breakthrough Award [R44]

Source: sbir.gov Agency: HHS Branch: NIH Program: SBIR Phase IIB Topic: PA-26-SBIR-R44-IIB Research Area: Health Technology / Biotech / Commercialization / Strategic Breakthrough Status: new Requirements: Phase IIB Strategic Breakthrough Award for SBIR companies with demonstrated Phase II results seeking additional commercialization funding.

$2,153,927Apr 6, 2027

grant

NIH

NIH STTR [R41/R42] – Clinical Trial Optional

Source: sbir.gov Agency: HHS Branch: NIH Program: STTR Phase I/II Topic: PA-26-STTR-R41R42 Research Area: Health Technology / Biotech / Clinical Research / University Partnerships Status: new Requirements: Parent STTR omnibus solicitation for NIH. Clinical trial optional. Requires small business-research institution partnership.

$2,153,927Apr 6, 2027

grant

NIH

NIH, CDC and FDA SBIR [R43/R44] – Clinical Trial Optional

Source: sbir.gov Agency: HHS Branch: NIH Program: SBIR Phase I/II Topic: PA-26-SBIR-R43R44 Research Area: Health Technology / Biotech / Clinical Research / Public Health Status: new Requirements: Parent SBIR omnibus solicitation for NIH, CDC, and FDA. Clinical trial optional. Covers broad health technology and biomedical research areas.

$2,153,927Apr 6, 2027